Carl Zeiss Meditec AG (1AFX)

Currency in EUR
42.78
+1.78(+4.34%)
Closed·

1AFX Financial Summary

Key Ratios

P/E Ratio24.91
Price/Book1.81
Debt / Equity28.46%
Return on Equity7.47%
Dividend Yield1.46%
EBITDA225.05M
Fair ValueUnlock
Fair Value UpsideUnlock

Statements Highlights

Period Ending:
2015
30/09
2016
30/09
2017
30/09
2018
30/09
2019
30/09
2020
30/09
2021
30/09
2022
30/09
2023
30/09
2024
30/09
* In Millions of EUR (except for per share items)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 1.71%
Dividend Yield
1.40%
Industry Median 1.32%
Annualised payout
0.60
Paid annually
5-Years Growth
-
Growth Streak

Earnings

Latest Release
Aug 07, 2025
EPS / Forecast
0.375 / 0.5084
Revenue / Forecast
549.60M / 551.66M
EPS Revisions
Last 90 days

FAQ

What were Carl Zeiss Meditec AG's earnings for the latest quarter?

The Carl Zeiss Meditec AG EPS (TTM) is 1.71. Carl Zeiss Meditec AG reported sales of 549.63, net income of 28.38, and EPS of 0.38 for the latest quarter.

What was Carl Zeiss Meditec AG's net income for the latest quarter?

Carl Zeiss Meditec AG's net income for the latest quarter was 28.38.

How did Carl Zeiss Meditec AG's performance compare year-over-year in the latest quarter?

The company's revenue moved from 560.02 in the previous quarter to 549.63 in the latest quarter, and net income moved from 45.33 to 28.38 compared to the previous quarter.

What is Carl Zeiss Meditec AG's net profit margin on a TTM basis?

Carl Zeiss Meditec AG's trailing twelve months (TTM) net profit margin is 8.65%.

How does Carl Zeiss Meditec AG's debt to equity ratio compare to industry standards?

Carl Zeiss Meditec AG's total debt-to-equity ratio is 28.46%.

What is Carl Zeiss Meditec AG's return on investment on a TTM basis?

Carl Zeiss Meditec AG's trailing twelve months (TTM) return on investment (ROI) is 7.47%.

How has Carl Zeiss Meditec AG's total revenue grown this year?

Carl Zeiss Meditec AG's total revenue was 560.02 in the previous quarter and 549.63 in the latest quarter.

What is Carl Zeiss Meditec AG's gross margin on a TTM basis?

Carl Zeiss Meditec AG's trailing twelve months (TTM) gross margin is 52.00%.

What was Carl Zeiss Meditec AG's revenue per share for the latest quarter?

Carl Zeiss Meditec AG's revenue per share for the latest quarter was 33.44.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.